Your browser doesn't support javascript.
loading
Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy.
Margara, Francesca; Psaras, Yiangos; Wang, Zhinuo Jenny; Schmid, Manuel; Doste, Ruben; Garfinkel, Amanda C; Repetti, Giuliana G; Seidman, Jonathan G; Seidman, Christine E; Rodriguez, Blanca; Toepfer, Christopher N; Bueno-Orovio, Alfonso.
Afiliação
  • Margara F; Department of Computer Science, University of Oxford, Oxford, UK.
  • Psaras Y; Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Wang ZJ; Department of Computer Science, University of Oxford, Oxford, UK.
  • Schmid M; Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Doste R; Department of Computer Science, University of Oxford, Oxford, UK.
  • Garfinkel AC; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Repetti GG; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Seidman JG; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Seidman CE; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Rodriguez B; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Toepfer CN; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
  • Bueno-Orovio A; Department of Computer Science, University of Oxford, Oxford, UK.
Sci Rep ; 12(1): 22501, 2022 12 28.
Article em En | MEDLINE | ID: mdl-36577774
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Medicina de Precisão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Medicina de Precisão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article